Quintara Discovery, a discovery & development specialist based in the San Francisco Bay Area, provides high-quality in vitro ADME profiling, bioanalysis services, and dedicated assay development and compound screening. We have accumulated extensive knowledge and insight in designing high-fidelity assays, obtaining and analyzing critical data, and prioritizing compounds for advancement. All experiments are performed in California by an experienced and talented scientific team who are available for real-time communication, discussion, and consultation. Our strong focus on lab operation, automation, instrumentation and project management enables an industry-leading turn-around delivery time with excellent quality. We stand behind all our assay results. With a customer-centric philosophy, Quintara strives to be your partner in drug Discovery & Development!
In the past 4 years, Quintara Discovery has worked with over 150 organizations, including 6 of the 10 largest biopharma companies in the world and many leading universities and institutes such as Stanford, UCSF, and the NIH. We have supported various start-up biotech companies that have gone IPO or been bought by large pharma/biotech companies. In 2014-2016, some of our clients were acquired at a significant premium by BMS, Amgen, Roche/Genentech, AbbVie, Merck, and Pfizer. We have a proven record of bringing success to our clients and their projects by an intense and undivided focus on experiments and compound profiling that are on the critical path.